Candin achieved a 45.4% durable clearance rate for the treated wart, nearly doubling the 23.4% clearance rate observed in the placebo group. Topline data were announced from a completed phase 3 trial ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mel Plaut Mel Plaut is a writer covering pets. They have tested hundreds of ...
The Milan, Italy-based pharmaceutical company Cassiopea S.p.A. has created a new therapeutic topical drug class to treat acne. But that’s just the beginning of its story. With its US subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results